Skip to main content
IceCure Medical Ltd. logo

IceCure Medical Ltd. — Investor Relations & Filings

Ticker · ICCM ISIN · IL0011224156 US Manufacturing
Filings indexed 260 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country US United States of America
Listing US ICCM

About IceCure Medical Ltd.

https://icecure-medical.com/

IceCure Medical Ltd. is a medical device company that develops and markets advanced cryoablation systems for the minimally invasive treatment of benign and malignant tumors. The company's core technology utilizes liquid nitrogen to achieve ultra-cold temperatures, enabling the precise freezing and destruction of targeted tissue while leaving adjacent tissue unharmed. Its flagship product, the ProSense® Cryoablation System, is used as an alternative to surgical tumor removal in various applications, including for the treatment of low-risk, early-stage breast cancer. The procedure is designed to be quick, performed under local anesthesia with a short recovery time. The company also develops systems for use in fields such as general surgery, dermatology, and neurology.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2026-05-19 English
6-K - IceCure Medical Ltd. (0001584371) (Filer)
Regulatory Filings
2026-05-13 English
424B5 - IceCure Medical Ltd. (0001584371) (Filer)
Regulatory Filings
2026-05-12 English
6-K - IceCure Medical Ltd. (0001584371) (Filer)
Regulatory Filings
2026-05-12 English
6-K - IceCure Medical Ltd. (0001584371) (Filer)
Regulatory Filings
2026-05-11 English
6-K - IceCure Medical Ltd. (0001584371) (Filer)
Regulatory Filings
2026-04-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.